Kensington, MD, United States of America

Nagaraju (Raju) Kanneboyina

This inventor holds 1 USPTO granted patent. Top assignee: Reveragen Biopharma, Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nagaraju (Raju) Kanneboyina. Retrieved from https://idiyas.com/inventor/nagaraju-raju-kanneboyina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Nagaraju (Raju) Kanneboyina

Introduction

Nagaraju (Raju) Kanneboyina is an accomplished inventor based in Kensington, MD. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of non-hormonal steroid modulators.

Latest Patents

Raju holds a patent for "Non-hormonal steroid modulators of NF-κβ for treatment of disease." This invention relates to compounds and methods that may be useful as treatments for various diseases. His innovative approach aims to provide alternative therapeutic options without the side effects associated with hormonal treatments.

Career Highlights

Raju is currently associated with Reveragen Biopharma, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective treatments that can improve patient outcomes in the biopharmaceutical sector.

Collaborations

Raju collaborates with notable colleagues, including John Michael McCall and Eric Hoffman. Their combined expertise enhances the research and development initiatives at Reveragen Biopharma, Inc.

Conclusion

Nagaraju (Raju) Kanneboyina is a prominent figure in the field of biopharmaceutical innovation, with a focus on developing non-hormonal treatments for diseases. His contributions are paving the way for new therapeutic options in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…